Back to results
US 12,697,402 B2Granted
Detection of colonic neoplasia in vivo using near-infrared peptide targeted against overexpressed cMet
AssigneeThe Regents of the University of Michigan
InventorsThomas D. Wang, Juan Zhou
Life of this patent
Estimating the term…
Abstract
The disclosure provides peptides, including labeled peptides, that selectively bind to the cMet protein. The disclosure also provides methods of detecting dysplastic cells and tissue, e.g., in the colon, providing early identification of precancerous and cancerous tissue.
Claims1
A peptide consisting of the amino acid sequence QQTNWSL set forth in SEQ ID NO:1.
Dependencies are inferred from the claim text.